ILIAD BIOTECHNOLOGIES, LLC
ILIAD BIOTECHNOLOGIES, LLC is a pertussis Vaccine founded in 2012 by Keith Rubin, M.D..
9
Funding Rounds
$102.9m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ke*** Ru**** M.** | - | - | - |
Funding series
Funding Series Analysis
The company ILIAD BIOTECHNOLOGIES, LLC has raised a total of $42.84m in funding over 9 rounds.
Key Insights:
- ILIAD BIOTECHNOLOGIES, LLC Funding Round, September 2022: $42.84m
- ILIAD BIOTECHNOLOGIES, LLC funding round, November 2019: $3.4m
- ILIAD BIOTECHNOLOGIES, LLC funding round, December 2018: $20m
- ILIAD BIOTECHNOLOGIES, LLC funding round, August 2018: $5m
- ILIAD BIOTECHNOLOGIES, LLC funding round, February 2018: $5m
- ILIAD BIOTECHNOLOGIES, LLC funding round, April 2017: $1.25m
- ILIAD BIOTECHNOLOGIES, LLC funding round, August 2016: $955k
- ILIAD BIOTECHNOLOGIES, LLC funding round, November 2015: $1m
- ILIAD BIOTECHNOLOGIES, LLC funding round, March 2021: $23.5m
ILIAD BIOTECHNOLOGIES, LLC Funding Round, September 2022
$42.84m
ILIAD BIOTECHNOLOGIES, LLC funding round, November 2019
$3.4m
ILIAD BIOTECHNOLOGIES, LLC funding round, December 2018
$20m
ILIAD BIOTECHNOLOGIES, LLC funding round, August 2018
$5m
ILIAD BIOTECHNOLOGIES, LLC funding round, February 2018
$5m
ILIAD BIOTECHNOLOGIES, LLC funding round, April 2017
$1.25m
ILIAD BIOTECHNOLOGIES, LLC funding round, August 2016
$955k
ILIAD BIOTECHNOLOGIES, LLC funding round, November 2015
$1m
ILIAD BIOTECHNOLOGIES, LLC funding round, March 2021
$23.5m
Industries
ILIAD BIOTECHNOLOGIES, LLC is active in the following industries: